Bruce A. Leicher
2016 - Momenta Pharmaceuticals
Compensation breakdown
Non-Equity Incentive Plan | $193,126 |
---|---|
Option Awards | $200,265 |
Salary | $414,655 |
Stock Awards | $771,993 |
Other | $12,998 |
Total | $1,593,037 |
Leicher received $772K in stock awards, accounting for 48% of the total pay in 2016.
Leicher also received $193.1K in non-equity incentive plan, $200.3K in option awards, $414.7K in salary and $13K in other compensation.
Rankings
In 2016, Bruce A. Leicher's compensation ranked 5,955th out of 14,075 executives tracked by ExecPay. In other words, Leicher earned more than 57.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,955 out of 14,075 | 58th |
Division Manufacturing | 2,159 out of 5,489 | 61st |
Major group Chemicals And Allied Products | 709 out of 1,895 | 63rd |
Industry group Drugs | 534 out of 1,538 | 65th |
Industry Biological Products, Except Diagnostic Substances | 100 out of 279 | 64th |
Leicher's colleagues
We found five more compensation records of executives who worked with Bruce A. Leicher at Momenta Pharmaceuticals in 2016.
2016
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2016
Scott Storer
Momenta Pharmaceuticals
Chief Financial Officer
2016
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Scientific Officer
2016
Matthew Ottmer
Momenta Pharmaceuticals
Chief Operating Officer
2016
Richard Shea
Momenta Pharmaceuticals